Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04604132 |
|---|---|
| Brief Title: | Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma (FIDES-03) |
| First Submitted : | October 21, 2020 |
| First Submitted that Met QC Criteria : | October 21, 2020 |
| First Posted : | October 27, 2020 |
| Last Update Submitted that Met QC Criteria : | March 7, 2022 |
| Last Update Posted : | March 8, 2022 |